PATENT CLAIM ANALYSIS

Application Number: 16045792
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-07
Patent Classification: ["514", "289000"]

Abstract:
Pharmaceutical compositions and methods for treating neurological disorders by administering same are provided. The compositions comprise dextromethorphan in combination with quinidine.

Claim (Index 6):
The method of  claim 1 , wherein at least one of the quinidine and the dextromethorphan is in a form of a pharmaceutically acceptable salt.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 95.0
- Lexical Diversity: 1.09524
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13415067', '11035213', '14863284', '14604397', '15130807']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7815595094812215
- 35 USC 102 Novelty (BERT): 0.6281101311132739
- Combined Prediction Score: 0.7662145716444269
- Mean Citation Score: 365.124732
- Max Citation Score: 596.3391
- Similarity Product: 533.3472792886735

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test